Safety of e-cigarettes and nicotine patches as stop-smoking aids in pregnancy: Secondary analysis of the Pregnancy Trial of E-cigarettes and Patches (PREP) randomized controlled trial.
Birth weight
e-cigarettes
nicotine
pregnancy
safety
smoking
vaping
Journal
Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118
Informations de publication
Date de publication:
17 Jan 2024
17 Jan 2024
Historique:
received:
07
07
2023
accepted:
16
11
2023
medline:
17
1
2024
pubmed:
17
1
2024
entrez:
17
1
2024
Statut:
aheadofprint
Résumé
The aim of this study was to examine the safety of e-cigarettes (EC) and nicotine patches (NRT) when used to help pregnant smokers quit. A recent trial of EC versus NRT reported safety outcomes in the randomized arms. We conducted a further analysis based on product use. Twenty-three hospitals in England and a stop-smoking service in Scotland took part. The participants comprised 1140 pregnant smokers. We compared women using and not using EC and NRT regularly during pregnancy. Measurements included nicotine intake compared with baseline, birth weight, other pregnancy outcomes, adverse events, maternal respiratory symptoms and relapse in early abstainers. Use of EC was more common than use of NRT (47.3% vs 21.6%, P < 0.001). Women who stopped smoking (abstainers) and used EC at the end-of-pregnancy (EOP) reduced their salivary cotinine by 45% [49.3 ng/ml, 95% confidence interval (CI) = -79.8 to -10]. Only one abstainer used NRT at EOP. In dual users, cotinine increased by 19% (24 ng/ml, 95% CI = 3.5-68). In women reporting a reduction of at least 50% in cigarette consumption, cotinine levels increased by 10% in those using nicotine products and by 9% in those who did not. Birth weights in dual users and exclusive smokers were the same (3.1 kg). Birth weight in abstainers using either nicotine product was higher than in smokers [3.3 kg, standard deviation (SD) = 0.7] versus 3.1 kg, SD = 0.6; difference = 0.15 kg, 95% CI = 0.05-0.25) and not different from abstainers not using nicotine products (3.1 kg, SD = 0.8). Abstainers and smokers using nicotine products had no worse pregnancy outcomes or more adverse events than abstainers and smokers not using them. EC users reported more improvements than non-users in cough [adjusted relative risk (aRR) = 0.59, 95% CI = 0.37-0.93] and phlegm (aRR = 0.53, 95% CI = 0.31-0.92), controlling for smoking status. EC or NRT use had no association with relapse. Regular use of e-cigarettes or nicotine patches by pregnant smokers does not appear to be associated with any adverse outcomes.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Cancer Research UK
ID : 16893
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 25356
Pays : United Kingdom
Informations de copyright
© 2024 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.
Références
Avşar TS, McLeod H, Jackson L. Health outcomes of smoking during pregnancy and the postpartum period: an umbrella review. BMC Pregnancy Childb. 2021;21(1):254.
Abraham M, Alramadhan S, Iniguez C, Duijts L, Jaddoe VW, Den Dekker HT, et al. A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis. PLoS ONE. 2017;12:e0170946.
Dempsey DA, Benowitz NL. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf. 2001;24:277-322.
Morales-Suárez-Varela M, Puig BM, Kaerlev L, Peraita-Costa I, Perales-Marín A. Safety of nicotine replacement therapy during pregnancy: a narrative review. Int J Environ Res Public Health. 2023;20:250.
Blanc J, Tosello B, Ekblad MO, Berlin I, Netter A. Nicotine replacement therapy during pregnancy and child health outcomes: a systematic review. Int J Environ Res Public Health. 2021;18:4004.
Taylor L, Claire R, Campbell K, Coleman-Haynes T, Leonardi-Bee J, Chamberlain C, et al. Fetal safety of nicotine replacement therapy in pregnancy: systematic review and meta-analysis. Addiction. 2021;116:239-277.
Mark KS, Farquhar B, Chisolm MS, Coleman-Cowger VH, Terplan M. Knowledge, attitudes, and practice of electronic cigarette use among pregnant women. J Addict Med. 2015;9:266-272.
Caraballo RS, Shafer PR, Patel D, Davis KC, McAfee TA. Peer reviewed: quit methods used by US adult cigarette smokers, 2014-2016. Prev Chronic Dis. 2017;14:160600.
McNeill A, Brose L, Robson D, Calder R, Simonavicius E, East K et al. Nicotine vaping in England: an evidence update including health risks and perceptions, September 2022. A report commissioned by the Office for Health Improvement and Disparities. London: Office for Health Improvement and Disparities; 2022.
Hartmann-Boyce J, Lindson N, Butler AR, McRobbie H, Bullen C, Begh R, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2022;(3):CD015170.
Froggatt S, Reissland N, Covey J. The effects of prenatal cigarette and e-cigarette exposure on infant neurobehaviour: a comparison to a control group. EClinMed. 2020;28:100602.
Kim S, Oancea SC. Electronic cigarettes may not be a ‘safer alternative’ of conventional cigarettes during pregnancy: evidence from the nationally representative PRAMS data. BMC Pregnancy Childb. 2020;20:557.
Regan AK, Bombard JM, O'Hegarty MM, Smith RA, Tong VT. Adverse birth outcomes associated with prepregnancy and prenatal electronic cigarette use. Obstet Gynecol. 2021;138:85-94.
Cohn AM, Elmasry H, Wild RC, Johnson AL, Abudayyeh H, Kurti A, et al. Birth outcomes associated with e-cigarette and non-e-cigarette tobacco product use during pregnancy: an examination of PATH data waves 1-5. Nicotine Tob Res. 2023;25:444-452.
Wen X, Thomas MA, Liu L, Moe AA, Duong PH, Griffiths ME, et al. Association between maternal e-cigarette use during pregnancy and low gestational weight gain. Int J Gynecol Obstet. 2023;162:300-308.
Hajek P, Przulj D, Pesola F, Griffiths C, Walton R, McRobbie H, et al. Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial. Nat Med. 2022;28:958-964.
Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019;380:629-637.
Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström test for cigarette dependence. Nicotine Tob Res. 2012;14:75-78.
Bowker K, Lewis S, Coleman T, Cooper S. Changes in the rate of nicotine metabolism across pregnancy: a longitudinal study. Addiction. 2015;110:1827-1832.
Panjari M, Bell R, Bishop S, Astbury J, Rice G, Doery J. A randomized controlled trial of a smoking cessation intervention during pregnancy. Aust NZ J Obst Gynaecol. 1999;39:312-317.
Reeves S, Bernstein I. Effects of maternal tobacco-smoke exposure on fetal growth and neonatal size. Exp Rev Obst Gynecol. 2008;3:719-730.
Brand JS, Gaillard R, West J, McEachan RR, Wright J, Voerman E, et al. Associations of maternal quitting, reducing, and continuing smoking during pregnancy with longitudinal fetal growth: findings from Mendelian randomization and parental negative control studies. PLoS Med. 2019;16:e1002972.
Miler JA, Hajek P. Resolution of chronic nasal Staphylococcus aureus infection in a non-smoker who started to use glycerine based e-cigarettes: antibacterial effects of vaping? Med Hypotheses. 2018;118:42-43.
Miler JA, Hajek P. Resolution of recurrent tonsillitis in a non-smoker who became a vaper. A case study and new hypothesis. Med Hypotheses. 2017;109:17-18.
Miler JA, Mayer B, Hajek P. Changes in the frequency of airway infections in smokers who switched to vaping: results of an online survey. J Addict Res Ther. 2016;7:290.
Robertson O, Bigg E, Puck TT, Miller BF, with the technical assistance of Elizabeth A. Appell. The bactericidal action of propylene glycol vapor on microorganisms suspended in air. I. J Exp Med. 1942;75:593-610.
Butler AR, Lindson N, Fanshawe TR, Theodoulou A, Begh R, Hajek P, et al. Longer-term use of electronic cigarettes when provided as a stop smoking aid: systematic review with meta-analyses. Prev Med. 2022;165:107182.